Vertex Pharmaceuticals SVP Ambrose sells shares for $632,726
Kristen Ambrose, Senior Vice President and Chief Accounting Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotechnology company with strong financial health according ...
Analysts’ Opinions Are Mixed on These Financial Stocks: S&P Global (SPGI), Victory Capital Holdings (VCTR) and United Fire Group (UFCS)
Analysts have been eager to weigh in on the Financial sector with new ratings on S&P Global (SPGI – Research Report), Victory Capital ...
Vertex stock price target raised to $520 at Truist Securities
Truist Securities increased the price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ: VRTX), a $121 ...
Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares.
Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q4 2024 Update
Davis Selected Advisers' 13F portfolio saw changes with stake increases in tech and travel, while reducing in financial and ...